A novel disease-causing mutation in AVPR2: Q96H

Area of Science:

• Genetics
• Molecular Biology
• Endocrinology

Background:

• Nephrogenic diabetes insipidus (NDI) is a condition characterized by the kidneys' inability to respond to arginine vasopressin (AVP).
• Genetic mutations in the arginine vasopressin receptor-2 (AVPR2) gene are a common cause of X-linked NDI.
• Understanding the molecular basis of AVPR2 dysfunction is crucial for diagnosing and potentially treating NDI.

Purpose of the Study:

• To identify the genetic cause of NDI in a 4-month-old male infant.
• To characterize a novel mutation in the AVPR2 gene and its functional implications.
• To investigate the role of the conserved Q96 residue in AVPR2 function.

Main Methods:

• Genetic testing (sequencing) of the AVPR2 gene.
• Protein sequence comparison across AVPR subtypes.
• Molecular modeling of the AVPR1 receptor.
• Analysis of mutation location relative to known disease-causing sites.

Main Results:

• A novel X-linked mutation, Q96H, was identified in the AVPR2 gene of the infant and his mother.
• The Q96 residue is located within a highly conserved motif in the AVPR2 protein.
• Molecular modeling suggests the equivalent residue in AVPR1 is vital for vasopressin binding.

Conclusions:

• The novel Q96H mutation in AVPR2 is the likely cause of NDI in this patient.
• The conserved Q96 residue is critical for the functional integrity of the AVPR2.
• This finding expands the spectrum of known AVPR2 mutations and their impact on NDI pathogenesis.